secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001398733-26-000020
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics appoints new CLO/ CCO; Braender steps down as CLO
------------------------------------------------------------------------

- Lori Braender steps down as CLO and CCO effective April 2, 2026; remains Corporate Secretary.
- Thomas Zalewski appointed CLO and CCO effective April 2, 2026; former Partner at Day Pitney.
- Zalewski receives inducement grant of 100k RSUs and 75k options, vesting over 3 years.
- Braender eligible for severance payments and accelerated vesting under separation agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000139873326000020/0001398733-26-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000139873326000020/aqst-20260316.htm
  HTML page:      https://secwatch.observer/filing/0001398733-26-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer